D. Oliver

发表

BRAF mutation leading to central nervous system rosai‐dorfman disease

D. Burns, T. Richardson, Megan B. Wachsmann, 2018, Annals of neurology.

Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma.

E. Maher, Song Zhang, V. Tiwari, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Metabolic Heterogeneity in Human Lung Tumors

B. Faubert, R. Deberardinis, R. Lenkinski, 2016, Cell.

The importance of plasma D‐2HG measurement in screening for IDH mutations in acute myeloid leukaemia

R. Collins, D. Rakheja, D. Oliver, 2016, British journal of haematology.

Transcriptionally Active HPV and Targetable EGFR Mutations in Sinonasal Inverted Papilloma

J. Bishop, D. Oliver, R. Chernock, 2019, The American journal of surgical pathology.

PATHOLOGY INFORMATICS SUMMIT 2018

David E. Breen, William B. Lober, Hamid R. Tizhoosh, 2018, Journal of Pathology Informatics.

Radiation-induced KRAS G12V mutant lung adenocarcinoma in a never smoker

H. Choy, D. Gerber, D. Oliver, 2016 .

Non-malignant respiratory epithelial cells preferentially proliferate from resected non-small cell lung cancer specimens cultured under conditionally reprogrammed conditions

Y. Kluger, D. Wheeler, J. Minna, 2016, Oncotarget.

Defining early mycosis fungoides: validation of a diagnostic algorithm proposed by the International Society for Cutaneous Lymphomas

L. Hynan, D. Oliver, A. Pandya, 2015, Journal of cutaneous pathology.

Spinal Pleomorphic Xanthoastrocytoma With a QKI-RAF1 Fusion

T. Richardson, Megan B. Wachsmann, D. Oliver, 2018, Journal of neuropathology and experimental neurology.

Lenalidomide-Associated Secondary B-Lymphoblastic Leukemia/Lymphoma-A Unique Entity.

Sharon Koorse Germans, P. Koduru, D. Oliver, 2020, American journal of clinical pathology.

Multiplex Fragment Analysis Identifies SARS-CoV-2 Variants

B. Cantarel, D. Oliver, Y. Xu, 2021, medRxiv.

Case Report of Fibro-Adipose Vascular Anomaly (FAVA) with Activating Somatic PIK3CA Mutation

D. Oliver, H. Hwang, Jordan H Driskill, 2022, Case reports in genetics.

Next-Generation Sequencing Directs Therapy and Delineates a Clonal Relationship in Mast Cell Sarcoma and Acute Myeloid Leukemia.

R. Collins, D. Oliver, T. Brown, 2019, JCO precision oncology.

Genome-Wide Analysis of Glioblastoma Patients with Unexpectedly Long Survival.

E. Maher, M. Snuderl, T. Taxter, 2019, Journal of neuropathology and experimental neurology.

Rapid progression to glioblastoma in a subset of IDH-mutated astrocytomas: a genome-wide analysis

E. Maher, A. Heguy, M. Snuderl, 2017, Journal of Neuro-Oncology.

Lactate Metabolism in Human Lung Tumors

Jamey D. Young, Quyen N. Do, B. Faubert, 2017, Cell.

Cytogenomic characterization of double minute heterogeneity in therapy related acute myeloid leukemia.

P. Koduru, D. Oliver, B. Haley, 2019, Cancer genetics.

Digital Droplet PCR for SARS-CoV-2 Resolves Borderline Cases

J. Malter, D. Oliver, J. Gagan, 2021, American journal of clinical pathology.

Hereditary Lung Cancer Syndrome Targets Never Smokers with Germline EGFR Gene T790M Mutations

J. Soh, S. Toyooka, W. Travis, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Does Tumor FDG-PET-Avidity Represent Enhanced Glycolytic Metabolism in Non-Small Cell Lung Cancer?

B. Faubert, R. Deberardinis, R. Lenkinski, 2019, The Annals of thoracic surgery.

Distinct immunophenotype of early T-cell progenitors in T lymphoblastic leukemia/lymphoma may predict FMS-like tyrosine kinase 3 mutations.

D. Oliver, N. Karandikar, Weina Chen, 2012, Annals of diagnostic pathology.

Infantile mixed phenotype acute leukemia (bilineal and biphenotypic) with t(10;11)(p12;q23);MLL-MLLT10.

D. Oliver, C. Zhang, Junke Zheng, 2010, Leukemia research.

Multiplex Fragment Analysis for Flexible Detection of All SARS-CoV-2 Variants of Concern

Jason Y. Park, B. Cantarel, D. Oliver, 2022, Clinical chemistry.

Histologic Transformation from Adenocarcinoma to Squamous Cell Carcinoma as a Mechanism of Resistance to EGFR Inhibition.

D. Gerber, D. Oliver, J. Sailors, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II–III astrocytomas and oligoastrocytomas

E. Maher, K. Fink, D. Burns, 2014, Journal of Neuro-Oncology.

Fever-range whole-body thermal therapy combined with cisplatin, gemcitabine, and daily interferon-α: A description of a phase I-II protocol

J. Bull, F. Strebel, D. Oliver, 2008, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Potential pitfalls of mass spectrometry to uncover mutations in childhood soft tissue sarcoma: A report from the Children’s Oncology Group

S. Spunt, S. Skapek, D. Hawkins, 2016, Scientific Reports.

Histologic transformation of EGFR mutant lung adenocarcinoma without exposure to EGFR inhibition.

D. Gerber, D. Oliver, J. Sailors, 2017, Lung cancer.

Serum D‐2‐hydroxyglutarate and the ratio of D‐2HG/L‐2HG predict IDH mutation in acute myeloid leukemia

R. Collins, D. Rakheja, D. Oliver, 2023, EJHaem.

Hereditary Lung Cancer Syndrome Targets Never Smokers with Germline EGFR Gene T790M Mutations

J. Soh, S. Toyooka, W. Travis, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

When Phenotype Does Not Match Genotype-The Importance of Returning to the Raw Data.

Megan B. Wachsmann, D. Oliver, U. Verma, 2019, The Journal of Applied Laboratory Medicine.